3646 results for «702»
3646 results
TAVI and complex coronary artery anatomy
18 Feb 2023 – From PCR Tokyo Valves 2023
What defines 'complex TAVI and coronary artery scenarios'? Join this session to discover when chimney stenting for threatening left coronary artery obstruction becomes the ideal alternative, using balloon-assisted BASILICA for valve-in-valve TAVR, and addressing tissue embolisation post-TAVI.
Mutual understanding of essential roles of co-medical staff supporting structural heart disease intervention
18 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session in japanese to learn more about the essential roles of co-medicals in structural heart disease intervention: the decision-making regarding the treatment and imaging procedure, strategies and evaluating effects and complications.
Mitral valve interventions
18 Feb 2023 – From PCR Tokyo Valves 2023
Discover various compelling mitral valve interventions in this session: newer vs. older generations of the MitraClip devices, safety and feasibility of balloon mitral valvotomy, catheter ablation efficacy, and more!
Complication and bailout of TAVI
18 Feb 2023 – From PCR Tokyo Valves 2023
As TAVI is never risk-free, learn about bailout techniques to counter various complications. This session explores cases such as failure to release aortic stenosis after implantation of a self-expanding valve, retrieving a pigtail catheter straightener dropped into aorta and balloon rupture during TAVI.
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
ViV challenges in degenerated sutureless bioprosthesis
08 Apr 2025
Watch this EuroIntervention image to learn how the collision of a TAV device during valve crossing in ViV TAVI can potentially cause instability or dehiscence of the sutureless bioprosthesis, contributing to severe poorly tolerated PVL.
